Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/365687


World Adult Infectious Diseases Vaccines Markets


Description:
New Innovations, Emerging Markets Propel Vaccine Industry

Though the global vaccines market accounts for approximately two percent of
the world pharmaceutical industry, the field has witnessed considerable
changes and positive growth over the past few years. The introduction of new
delivery systems, novel and combination vaccines, and improved vaccination
rates in emerging markets are expected to significantly impact the industry.

This Frost & Sullivan analysis provides a comprehensive evaluation of the
world adult infectious diseases vaccines markets. By offering a detailed analysis

of major segments and publicly-funded programs aimed at increasing
immunization rates, this study allows firms to take advantage of key
industry trends.

Nasal Inoculation Opens Doors to Lucrative Growth Opportunities

The most promising advancement for new delivery methods for influenza
vaccines is the development of a nasal delivery vaccine. One breakthrough
product is currently awaiting final approval by the FDA.This would be the first

nasal delivery flu vaccine and should prove profitable in markets where
patients’ fear of needles is a major challenge.

Nasal delivery strategies are being employed in an effort to boost
immunization rates. By focusing on the pediatric sector, one manufacturer is
attempting to create a new market opportunities for the vaccines, states the
author of this study.

Lack of Awareness Regarding the Health Risks of Hepatitis Hinders Market

Though hepatitis B is considered a third-world disease, a significant number of
European and North American adults contract the illness each year. A large

portion of the high-risk adult population is simply not aware of the potential

health problems associated with the disease or the fact that their lifestyle may
put them at increased risk.

This is especially true for sexually active males with multiple partners. Even
among the more knowledgeable high-risk groups, increased awareness does
not always translate into a need to get vaccinated,” says the analyst.
For example, recent surveys found that the top reason these individuals had

not received the hepatitis B vaccination is they did not consider it a
medical priority.

This Frost & Sullivan research provides the most current market intelligence,
enabling industry participants to implement effective strategies for future success.

Additional Information

Market Participants
Acambis, Inc.
Antex Biologics, Inc.
Aventis S.A.

Aviron
Biochem Pharma, Inc./Shire Pharmaceuticals

Group plc

Centers for Disease Control and Prevention
Chiron Corp.
Epimmune, Inc.

GlaxoSmithKline

GlaxoSmithKline Biologicals

Hepatitis B Foundation
ImClone Systems, Inc.
Maxim Pharmaceuticals, Inc.
MedImmune, Inc.
Merck and Co.
Nabi Corp.

National Coalition for Adult Immunization

PowderJect Pharmaceuticals plc
ProdiGene, Inc.
Protein Sciences Corp.
Rhein Biotech N.V.


Contents: 1. Executive Summary
A. Executive Summary

1. Introduction

2. Total Market
A. Overview

1. Introduction

2. The Global Vaccine Market

3. Market Shares In Major Regional Vaccine Markets

4. Vaccine-Preventable Infectious Diseases

5. Vaccine-Preventable Adult Infectious Diseases
B. Competitive Analysis

1. Introduction

2. Aventis Pasteur

3. GlaxoSmithKline

4. American Home Products - Wyeth

5. Merck

6. Chiron Corporation

7. PowderJect

8. Berna

9. Rhein Biotech

10. Key Findings of Competitive Analysis

11. Market Engineering Analysis
C. Research and Development

1. Major Vaccine Producers Research and Development Initiatives

2. New Delivery Mechanisms
D. Market Engineering Awards

1. Merger and Acquisition Strategy Award

2. Marketing Strategy Award

3. Market Engineering Leadership Award

4. Technology Innovation Award

5. Product Line Strategy Award

3. Adult Hepatitis Vaccines Market
A. Disease Overview

1. Disease Overview

2. Existing Products

3. Mass Vaccination Programs by Country
B. Market Dynamics

1. Adult Vaccine Recommendations

2. High Risk Groups

3. Challenges

4. Restraints

5. Drivers
C. Forecasts and Trends

1. Hepatitis A Demand Analysis

2. Hepatitis B Demand Analysis

3. Pricing Analysis

4. Revenue Forecasts

5. Market Engineering Analysis

6. Technology Trends

7. Strategic Recommendations

4. Adult Influenza Vaccines Market
A. Disease Overview

1. Disease Overview

2. Existing Products
B. Market Dyanamics

1. Challenges

2. Drivers

3. Target Markets
C. Forecasts and Trends

1. Pricing Analysis

2. Demand Analysis

3. Revenue Forecasts

4. Market Engineering Analysis

5. Technology Trends

6. Market Trends
D. Strategic Recommendations

1. Strategic Recommendations for Market Challenge 1

2. Strategic Recommendations for Market Challenge 2

3. Strategic Recommendation for Market Challenge 3

List Of Figures

Chapter 2

Total Infectious Diseases Vaccines Market: Global Vaccine Revenues by Region (World), 2000
Total Infectious Diseases Vaccines Market: Global Vaccine Revenues by Producer (World), 2000
Total Infectious Diseases Vaccines Market: Global Vaccine Revenues by Producer (U.S. and Canada), 2000
Total Infectious Diseases Vaccines Market: Global Vaccines Revenues by Producer (Europe), 2000
Total Infectious Diseases Vaccines Market: Global Vaccines Revenues by Producer (Rest-of-World), 2000
Total Infectious Diseases Vaccines Market: Global Vaccine Revenues by Producer (World), 1999-2000

Chapter 3

Adult Hepatitis Vaccines Market: Hepatitis A-- Estimated Number of Cases per Region (World), 1990
Adult Hepatitis Vaccines Market: Endemicity of Hepatitis A Infection (World), 2000
Adult Hepatitis Vaccines Market: Patterns of Chronic Hepatitis B Infection (World), 2000
Adult Hepatitis Vaccines Market: Impact of Top Industry Challenges (World), 2001-2005
Adult Hepatitis Vaccines Market: Impact of Top Industry Restraints (World), 2001-2005
Adult Hepatitis Vaccines Market: Impact of Top Industry Drivers (World), 2001-2005
Adult Hepatitis Vaccines Market: Revenue Forecasts (World), 1997-2005

Chapter 4

Adult Influenza Vaccine Market : Overall Leading Causes of Mortality (U.S.), 1999
Adult Influenza Vaccine Market: Impact of Top Industry Challenges (World), 2001-2005
Adult Influenza Vaccine Market: Impact of Top Industry Drivers (World), 2001-2005
Total Adult Influenza Vaccine Markets: Revenue Forecasts (World), 1997-2005




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/365687

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 23/11/2009 10:05:42
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
World Adult Infectious Diseases Vaccines Markets
Web Address:
http://www.researchandmarkets.com/reports/365687
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License €2,989.00
Electronic (PDF) - Enterprisewide €3,996.00
Electronic and Hard Copy (PDF) - Enterprisewide €4,332.00 + EUR€ 50.00 Shipping/Handling *
Electronic and Hard Copy (PDF) - Site License €3,324.00 + EUR€ 50.00 Shipping/Handling *
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 23/11/2009 10:05:42

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)